FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

636811000001106: Megace 160mg tablets (Bausch & Lomb UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1265391000001111 Megace 160mg tablets (Bausch & Lomb UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1265401000001114 Megace 160mg tablets (Bausch & Lomb UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Is a Product containing precisely megestrol acetate 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has active ingredient Megestrol acetate false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has active ingredient Antineoplastic agent false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Is a Megace true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has specific active ingredient Megestrol acetate true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Is pack of False Megace 160mg tablets (Bausch & Lomb UK Ltd) Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has AMP True Megace 160mg tablets (Bausch & Lomb UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start